Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure

Journal of the American Heart Association

  ^{1    1    2    2    2    3    3    4    5    6    6    6    7} 

[1] Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, United Kingdom;Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom;Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany;Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany;Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom;Program of Cardiovascular Diseases, Centre for Applied Medical Research, Navarra Institute for Health Research, University of Navarra, Pamplona, Spain;CIBERCV, Carlos III Institute of Health, Madrid, Spain;Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium;Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium;R & D Group VitaK, Maastricht University, Maastricht, The Netherlands;

关键词: biomarker;    heart failure;    proteomics;    risk stratification;   

DOI  :  10.1161/JAHA.116.005432

来源: publisher

【 授权许可】

Unknown